Intraoperative localization of the sentinel node in breast cancer: Technical aspects of lymphoscintigraphic methods

Seminars in Surgical Oncology

Volumn 15, Issue 4, 1998, Pages 268-271

  De Cicco, Concetta ^a   Chinol, Marco ^a   Paganelli, Giovanni ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Axilla; Biopsy; Breast neoplasms; Carcinoma in situ; Dyes; Infiltrating duct carcinoma; Lymph node excision; Lymph nodes; Lymphatic metastasis radionuclide imaging; Melanoma; Neoplasm staging; Organotechnetium compounds; Patient selection; Predictive value of tests; Prognosis; Radioimmunodetection; Radionuclide imaging instrumentation

Indexed keywords

LYMPHOSCINT; SERUM ALBUMIN; SERUM ALBUMIN TC 99M; TECHNETIUM 99M; UNCLASSIFIED DRUG;

AXILLARY LYMPH NODE; BREAST CANCER; CANCER LOCALIZATION; CANCER STAGING; COLLOID; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; INTRATUMORAL DRUG ADMINISTRATION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; PARTICLE SIZE; PRIORITY JOURNAL; SCINTISCANNING; TRANSDERMAL DRUG ADMINISTRATION; TUMOR BIOPSY;

EID: 0031789247     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(199812)15:4<268::AID-SSU16>3.0.CO;2-I     Document Type: Conference Paper

References (18)

1. Tubiana M, Holland R, Kopans DB, et al: Commission of the European Communities "Europe Against Cancer" Programme. European School of Oncology Advisory Report. Management of non-palpable and small lesions found in mass breast screening [Review]. Eur J Cancer 1994;30:538-547.
2. Fisher B, Wolmark N, Bauer M, et al: The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histological nodal status in carcinoma of the breast. Surg Gynecol Obstet 1981;152:765-772.
3. Consensus conference. Adjuvant chemotherapy for breast cancer. JAMA 1985;254:3461-3463.
4. Moffat FL Jr, Senofsky GM, Davis K, et al: Axillary node dissection for early breast cancer: some is food, but all is better. J Surg Oncol 1992;51:8-13.
5. Silverstein MJ, Gierson ED, Waisman JR, et al: Axillary lymph node dissection for Tla breast carcinoma. Is it indicated? Cancer 1994;73:664-667.
6. Morton D, Wen D, Cochran A: Management of early-stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy: an alternative to routine elective lymphadenectomy or "watch and wait." Surg Oncol Clin North Am 1992;1:247-259.
7. Giuliano AE, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel Iymphadenectomy for breast cancer [comment in: Ann Surg 1997;225:125-127]. Ann Surg 1994;220:391-401.
8. Pettaway CA, Pisters LL, Dinney CP, et al: Sentinel lymph node dissection for penile carcinoma: the M.D. Andersen Cancer Center experience. J Urol 1995;154:1999-2003.
9. Levenback C, Burke TW, Morris M, et al: Potential applications of intraoperative lymphatic mapping in vulvar cancer. Gynecol Oncol 1995;59:216-220.
10. van der Veen H, Hoekstra OS, Paul MA, et al: Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy. Br J Surg 1994;81:1769-1770.
11. Frag DN, Weaver DL, Alex JC, Fairbank JT: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-340
12. Pijpers R, Meijer S, Hoekstra OS: Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer J Nucl Med 1997;38:366-368.
13. Albertini JJ, Lyman GH, Cox C, et al: Lymphatic mapping and sentinel node biopsy in the patients with breast cancer [comment in: JAMA 1997;277:791-792]. JAMA 1996;276:1818-1822.
14. Offodile R, Hoh C, Barsky SH, et al: Minimally invasive breast carcinoma staging usine lymphatic mapping with radiolabeled dextran [Review] Cancer 1998;82:1704-1708.
15. Grant RN, Tabah EJ, Adair FE: The surgical significance of the subareolar plexus in cancer of the breast. Surgery 1959;33:71-78.
16. Turner-Warwick RT: The lymphatics of the breast. Br J Surg 1959;46(200).574-582.
17. Borgstein PJ, Meijer S, Pijpers R, Intradermal blue dye to identify sentinel Iymph-node in breast cancer [comment in: Lancet 1997,350(9082):958]. Lancet 1997;349(9066):1668-1669.
18. Veronesi U, Paganelli G, Galimberti V, et al: Sentinel-node biopsy to avoid axillary dissection in breast cancer patients with clinically negative lymph-nodes [comment in: Lancet 1997;350(9080):808-809]. Lancet 1997;349(9069):1864-1867.